FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Kirkpatrick Andrew J

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/18/2017 

3. Issuer Name and Ticker or Trading Symbol

ACCURAY INC [ARAY]

(Last)        (First)        (Middle)

1310 CHESAPEAKE TERRACE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP, Global Operations /

(Street)

SUNNYVALE, CA 94089       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   241888   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)     (2) 9/30/2021   Common Stock   28000   $4.01   D    
Non-Qualified Stock Option (right to buy)     (3) 2/27/2019   Common Stock   10000   $4.67   D    
Non-Qualified Stock Option (right to buy)     (4) 11/30/2026   Common Stock   56800   $5.05   D    
Non-Qualified Stock Option (right to buy)     (5) 10/31/2019   Common Stock   30000   $5.77   D    
Non-Qualified Stock Option (right to buy)     (6) 5/29/2019   Common Stock   10000   $6.16   D    
Non-Qualified Stock Option (right to buy)     (7) 10/31/2018   Common Stock   7500   $6.32   D    
Non-Qualified Stock Option (right to buy)     (8) 10/29/2020   Common Stock   9000   $6.58   D    
Non-Qualified Stock Option (right to buy)     (9) 6/30/2020   Common Stock   10000   $6.63   D    
Non-Qualified Stock Option (right to buy)     (10) 10/31/2022   Common Stock   18700   $6.96   D    
Non-Qualified Stock Option (right to buy)     (11) 1/31/2018   Common Stock   2000   $9.52   D    
Non-Qualified Stock Option (right to buy)     (12) 8/17/2017   Common Stock   35000   $13.45   D    
Non-Qualified Stock Option (right to buy)     (11) 12/31/2017   Common Stock   3000   $15.22   D    

Explanation of Responses:
(1)  90,507 shares are held directly by the reporting person, of which 20,264 of these shares were acquired through the Accuray 2007 Employee Stock Purchase Plan. An additional 16,092 shares were acquired through the vesting and release of MSUs granted on 10/31/2013. The remaining 54,151 shared directly owned were acquired through the vesting and release of RSUs. Also included in this total are 7,500 remaining unvested granted on 10/31/2013; 8,681 remaining unvested RSUs granted on 10/31/2014; 37,500 remaining unvested RSUs granted on 10/31/2015; 75,000 shares granted on 6/30/2016 which will vest 33% on 6/30/2017, 33% on 7/2/2018 and 34% on 7/1/2019; & 22,700 RSUs granted on 11/30/2016 which will vest in equal amounts on 11/30/2017, 11/30/2018, 12/2/2019 and 11/30/2020.
(2)  Fully vested on 10/01/2015.
(3)  Fully vested on 01/28/2013.
(4)  The shares subject to option vest 25% on the first anniversary of the grant, 11/30/2017, and the remaining shares vest in equal monthly installments until fully vested on 11/30/2020.
(5)  Fully vested on 10/01/2013.
(6)  Fully vested on 05/29/2013.
(7)  Fully vested on 10/31/2012.
(8)  Fully vested on 10/01/2014.
(9)  Fully vested on 06/30/2014.
(10)  Fully vested on 10/31/2016.
(11)  Fully vested on 12/31/2011.
(12)  Fully vested on 07/30/2011.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Kirkpatrick Andrew J
1310 CHESAPEAKE TERRACE
SUNNYVALE, CA 94089


SVP, Global Operations

Signatures
By: Kristen Howells For: Andrew J Kirkpatrick 5/25/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Accuray (NASDAQ:ARAY)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more Accuray Charts.
Accuray (NASDAQ:ARAY)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more Accuray Charts.